This inventor holds 1 USPTO granted patent. Top assignee: Faron Pharmaceuticals Oy. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Alexander Spicer: Innovator in Medical Treatments
Introduction
Alexander Spicer is a notable inventor based in Turku, Finland. He has made significant contributions to the field of medicine, particularly in the treatment of systemic inflammatory response syndrome (SIRS). His innovative approach combines the administration of specific agents to enhance therapeutic outcomes.
Latest Patents
Spicer holds a patent for a method titled "Treatment of diseases with sequential administration of an agent capable of up-regulating CD73 and glucocorticoids." This method involves the sequential administration of an agent that up-regulates CD73 in combination with glucocorticoids. The innovative aspect of this patent lies in the timing of the administration, where the agent capable of up-regulating CD73 is given prior to the glucocorticoid or an agent that agonizes the glucocorticoid receptor. This method aims to prevent and treat SIRS effectively.
Career Highlights
Spicer is associated with Faron Pharmaceuticals Oy, a company dedicated to advancing medical treatments. His work focuses on developing therapies that address critical health challenges. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical innovation.
Collaborations
One of his notable collaborators is Juho Jalkanen, with whom he has worked on various projects aimed at enhancing treatment methodologies. Their combined expertise contributes to the advancement of medical science.
Conclusion
Alexander Spicer's contributions to medical innovation, particularly through his patented methods, highlight his role as a key figure in the fight against systemic inflammatory response syndrome. His work at Faron Pharmaceuticals Oy exemplifies the impact of dedicated research and collaboration in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile